Specialty Pharmacy

Zepatier is already approved in the United States and Canada for treatment of hepatitis C.

Prescribers and patients can no longer blindly rely on simple and straightforward drug delivery in specialty pharmacy.

CDC raises concerns about mother-to-child transmission of hepatitis C virus.

Ipilimumab combined with local peripheral treatments shows promise in malignant melanoma.

Researchers seek to induce broadly neutralizing antibodies to block numerous HIV variants.

Top news of the day from across the health care landscape.

More than a half-billion people may have diabetes worldwide.

Intestinal microbiota may help predict rheumatoid arthritis symptom severity and frequency.

Stage 2 colon cancer patients administered adjuvant chemotherapy survived significantly longer than patients who did not.

United States Preventive Service Task Force screening guidelines for diabetes found to miss more than half of high-risk patients.

Burdock root, or gobo, associated with lower rates of colon cancer and colitis.

Chemotherapy drug may cause the loss of hearing during the treatment of testicular cancer.

Overexpression of Aurora Kinase could potentially inhibit a tumor suppressing gene.

The specialty pharmacist has to balance myriad competing priorities in managing a specialty therapy regimen.

Top articles of the week on Specialty Pharmacy Times.

Top news of the week from across the health care landscape.

Understanding cellular mechanism can improve treatment of chronic inflammatory disease.

Research could lead to improved personalized therapies for acute myeloid leukemia.

Selenocompounds were able to kill up to 80% of cancer cells in mice.

Specialty pharmacies need to maintain services that ensure optimal patient care and outcomes.

Patients treated for high cholesterol showed improved survival in bowel, breast, lung, and prostate cancers.

Researchers target causes of severe depression in MS patients.

Adlyxin is a once-daily injection that improves glycemic control in type 2 diabetes.

Top news of the day from across the health care landscape.

Analysis of HOX gene able to predict survival in ovarian cancer.

Participants who lost weight showed decreased expression of proteins that promote tumor-related angiogenesis.

Standardizing measurements across the lifecycle of a prescription will help specialty pharmacies demonstrate success.

Analysis finds health plans need to examine total treatment costs instead of just drug costs.